Imprint Wealth’s AbbVie ABBV Stock Holding History

Imprint Wealth’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$9.81K	Sell	39 -7	-15%	-$1.51K	0.04%	129
2026 Q1	$10K	Sell	46 -79	-63%	-$17.5K	0.05%	123
2025 Q4	$28.6K	Buy	125 +45	+56%	+$10.3K	0.13%	76
2025 Q3	$18.5K	Buy	+80	New	+$16.3K	0.06%	136
2024 Q1	$3.93M	Buy	21,722 +5,276	+32%	+$909K	0.95%	19
2023 Q4	$2.55M	Buy	16,446 +51	+0.3%	+$7.43K	2.05%	8
2023 Q3	$2.44M	Buy	16,395 +601	+4%	+$88.2K	2.07%	9
2023 Q2	$2.13M	Sell	15,794 -1,171	-7%	-$172K	1.34%	15
2023 Q1	$2.69M	Buy	+16,965	New	+$2.59M	1.77%	10

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Imprint Wealth's ABBV Position: Q2 2026 in Review

Imprint Wealth reduced its AbbVie (ABBV) stake by 15% in Q2 2026, selling an estimated $1.51K and leaving 39 shares worth $9.81K. The position accounts for 0.04% of the portfolio, ranked #129.

Imprint Wealth first reported a position in ABBV in Q1 2023 and has held it in 9 quarters since. The position peaked at $3.93M in Q1 2024. 4,224 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Imprint Wealth held 39 shares of AbbVie worth $9.81K as of Q2 2026.
Imprint Wealth sold 7 AbbVie shares in Q2 2026, an estimated $1.51K.
AbbVie made up 0.04% of Imprint Wealth's portfolio in Q2 2026, its #129 holding.
Imprint Wealth first reported a position in AbbVie in Q1 2023 and has held it in 9 quarters since.
Imprint Wealth's AbbVie position peaked at $3.93M in Q1 2024.
4,224 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Imprint Wealth's 13F filing for Q2 2026, filed 14 Aug 2026.